共 226 条
[31]
Giske CG(2016)Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Microb Drug Resist 22 360-undefined
[32]
Harbarth S(1990)Increased azithromycin susceptibility of multidrug-resistant gram-negative bacteria on RPMI-1640 agar assessed by disk diffusion testing Drugs Exp Clin Res 16 615-undefined
[33]
Hindler JF(undefined)Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of undefined undefined undefined-undefined
[34]
Kahlmeter G(undefined) synergy of colistin combinations against colistin-resistant undefined undefined undefined-undefined
[35]
Olsson-Liljequist B(undefined), undefined undefined undefined-undefined
[36]
Paterson DL(undefined), and undefined undefined undefined-undefined
[37]
Rice LB(undefined) isolates undefined undefined undefined-undefined
[38]
Stelling J(undefined)Azithromycin exerts bactericidal activity and enhances innate immune mediated killing of MDR Achromobacter xylosoxidans undefined undefined undefined-undefined
[39]
Struelens MJ(undefined)Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens undefined undefined undefined-undefined
[40]
Vatopoulos A(undefined)Correlation of checkerboard synergy testing with time-kill analysis and clinical outcomes of extensively drug-resistant Acinetobacter baumannii respiratory infections undefined undefined undefined-undefined